Sarah Gerlo

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Top Venues

The Journal of infectious diseases

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Marie-Angélique De Scheerder, Sophie Degroote, Mareva Delporte, Maja Kiselinova, Wim Trypsteen, Lara Vincke, Evelien De Smet, Bram Van Den Eeckhout, Loïc Schrooyen, Maxime Verschoore, Camilla Muccini, Sophie Vanherrewege, Els Caluwe, De Buyser Stefanie, Sarah Gerlo, Evy E Blomme, Linos Vandekerckhove
In depth analysis of the HIV reservoir confirms effectiveness and safety of DTG/3TC in a phase 4 randomized controlled switch trial (RUMBA). The Journal of infectious diseases (2024)
Bram Van Den Eeckhout, Leander Huyghe, Sandra Van Lint, Elianne Burg, Stéphane Plaisance, Frank Peelman, Anje Cauwels, Gilles Uzé, Niko Kley, Sarah Gerlo, Jan Tavernier
Selective IL-1 activity on CD8 + T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication. Journal for immunotherapy of cancer 9 (11) (2022)
Wim Trypsteen, Jolien Van Cleemput, Willem van Snippenberg, Sarah Gerlo, Linos Vandekerckhove
On the whereabouts of SARS-CoV-2 in the human body: A systematic review. PLoS pathogens 16 (10) (2020)
Bram Van Den Eeckhout, Lien Van Hoecke, Elianne Burg, Sandra Van Lint, Frank Peelman, Niko Kley, Gilles Uzé, Xavier Saelens, Jan Tavernier, Sarah Gerlo
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant. NPJ vaccines 5 (1) (2020)